公司資料
Corbus Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- CRBP
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
10.69 USD (+2.99%)
收盤價
最後更新: 2026年8月24日
140M USD
市值
股價為何變動
As of Aug 24, 2026, CRBP closed up 2.99% at $10.69. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Corbus Pharmaceuticals is a biotechnology company focused on inflammation, oncology, and endocannabinoid biology. Its story is built around a narrow set of clinical programs and strategic repositioning.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Corbus sits in specialty biotechnology.
商業模式特徵
The company depends on clinical data, target selection, and the ability to create a differentiated pipeline in immune disease and cancer.
生技產業定位
Corbus is a small-cap catalyst name whose valuation is heavily dependent on program progress.
未來催化劑
- Corbus’s catalysts are CRB-701 and CRB-913, with oncology and obesity updates doing most of the work. The company will be judged on whether its next data can support a larger development step.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。